Close

Unusual 11 Mid-Day Movers 9/23: (IMPV) (BLRX) (TWTR) Higher; (ENPH) (APPS) (RAVE) Lower

Go back to Unusual 11 Mid-Day Movers 9/23: (IMPV) (BLRX) (TWTR) Higher; (ENPH) (APPS) (RAVE) Lower

Oppenheimer Remains Sidelined Following Endo Int'l's (ENDP) New CEO Appointment

September 26, 2016 10:04 AM EDT

Oppenheimer reiterated a Perform rating on Endo International plc (NASDAQ: ENDP), following the company's announced appointment of Paul Campanelli to president and chief executive officer. Mr. Campanelli joined ENDP in 2015 through the acquisition of Par Pharmaceuticals and most recently served as the CEO of Par. Mr. Campanelli's... More

Piper Jaffray Reiterates Neutral as Endo Int'l (ENDP) Announces Paul Campanelli as New CEO

September 26, 2016 8:26 AM EDT

Piper Jaffray reiterated a Neutral rating and $19.00 price target on Endo International plc (NASDAQ: ENDP) following the company's announcement appointment of Paul Campanelli as CEO effective immediately. Mr. Campanelli was responsible for the 2014 acquisition of JHP Pharma, which gave Par a sizable generic injectibles business and more importantly gave the... More

salesforce.com (CRM) Takeover of Twitter (TWTR) 'Extremely Risky' - Evercore ISI

September 23, 2016 3:45 PM EDT

Everecore ISI is out cautious on salesforce.com (NYSE: CRM) amid today's rumor it is interested in buying Twitter (NYSE: TWTR). Analyst Kirk Materne said this is a 'bridge too far' for the company and the company... More

Rumored Forever, Twitter (TWTR) May Have Finally Put the 'For Sale' Sign Up

September 23, 2016 1:31 PM EDT

If you're not living under a rock, you've heard the news that Twitter's (NYSE: TWTR) board may have finally gotten the memo that it can't go it alone and it's time to sell itself. Shares of the social media provider are up 18.4% today following the news break from CNBC's David Faber this morning. Faber said suitors are believed to... More